| Name | Title | Contact Details |
|---|
Stelexis` mission is to become the leading cancer therapeutics company, through the discovery and development of novel drugs, utilizing its proprietary platform to selectively target pre-cancerous stem cells. The company will initially focus on therapeutics for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
Copernicus is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Promeddx is a Norton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Degge Group is a Arlington, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Targacept`s clinical pipeline is built on a unique class of therapeutic targets.